杨振, 李帅, 冯子煜, 张智阳, 武玉东. 上尿路尿路上皮癌患者根治术前行输尿管镜活检的临床研究[J]. 中国肿瘤临床, 2020, 47(18): 925-928. DOI: 10.3969/j.issn.1000-8179.2020.18.663
引用本文: 杨振, 李帅, 冯子煜, 张智阳, 武玉东. 上尿路尿路上皮癌患者根治术前行输尿管镜活检的临床研究[J]. 中国肿瘤临床, 2020, 47(18): 925-928. DOI: 10.3969/j.issn.1000-8179.2020.18.663
Zhen Yang, Shuai Li, Ziyu Feng, Zhiyang Zhang, Yudong Wu. Clinical application of ureteroscopic biopsy in patients with upper tract urothelial carcinoma before surgery[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(18): 925-928. DOI: 10.3969/j.issn.1000-8179.2020.18.663
Citation: Zhen Yang, Shuai Li, Ziyu Feng, Zhiyang Zhang, Yudong Wu. Clinical application of ureteroscopic biopsy in patients with upper tract urothelial carcinoma before surgery[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(18): 925-928. DOI: 10.3969/j.issn.1000-8179.2020.18.663

上尿路尿路上皮癌患者根治术前行输尿管镜活检的临床研究

Clinical application of ureteroscopic biopsy in patients with upper tract urothelial carcinoma before surgery

  • 摘要:
      目的  探讨CT尿路造影(computed tomography urography,CTU)诊断明确的上尿路尿路上皮癌(upper tract urothelial carcino-ma,UTUC)患者行根治性肾输尿管切除(radical nephroureterectomy,RNU)术前是否有必要行输尿管镜活检。
      方法  回顾性分析2011年9月至2020年5月郑州大学第一附属医院73例术后病理确诊为UTUC患者的病例资料,比较CTU与输尿管镜活检诊断UTUC的阳性率,并分析输尿管镜活检与根治术后肿瘤病理分级的不一致性。
      结果  73例患者中70例行CTU检查者均提示异常,确诊阳性率为88.6%(62/70),术后病理证实均为尿路上皮肿瘤。行CTU检查后又行输尿管镜活检患者为61例,确诊阳性率为91.8%(56/61)。输尿管镜活检为临床高级别、低级别肿瘤分别占39.3%(24/61)、52.5%(32/61),术后病理诊断为高级别和低级别肿瘤分别占77.1%(47/61)和22.9%(14/61)。输尿管镜活检为临床低级别的肿瘤中,56.2%(18/32)术后病理升级为高级别肿瘤。CTU检查与输尿管镜活检诊断UTUC的阳性率无显著性差异(P=0.537)。
      结论  输尿管镜活检为临床低级别肿瘤的患者术后病理有明显的升级风险。对于CTU诊断明确,拟行RNU的UTUC患者,术前不建议行输尿管镜活检。

     

    Abstract:
      Objective  To investigate whether ureteroscopic biopsy was necessary for patients with upper tract urothelial carcinoma (UTUC), diagnosed by computed tomography urography (CTU), before radical nephroureterectomy (RNU).
      Methods  We conducted a retrospective study of 73 patients who were diagnosed with UTUC after surgery in The First Affiliated Hospital of Zhengzhou University from September 2011 to May 2020. We compared the UTUC positive rate between CTU and ureteroscopic biopsy. In addition, the discordance in grading between ureteroscopic biopsy and surgical pathology findings was analyzed.
      Results  Seventy of the 73 patients underwent CTU, and all of them showed abnormalities. The positive rate of diagnosis was 88.6% (62/70), and all tumors were pathologically confirmed as urothelial tumors. Sixty-one patients underwent ureteroscopic biopsy, and the positive rate of diagnosis was 91.8% (56/61). At biopsy, 39.3%(24/61) of patients had clinically high-grade tumors while 52.5%(32/61) had clinically low-grade tumors. At the final pathology, 77.1%(47/61) of patients had pathologically high-grade tumors while 22.9% (14/61) had pathologically low-grade tumors. Among the cases involving clinically low-grade tumors on biopsy, tumor grade was upgraded after surgery in 56.2% (18/32) of cases. There was no difference in the positive rate of UTUC diagnose between CTU and ureteroscopic biopsy (P=0.537).
      Conclusion  There is a significant risk of up-grading in patients with clinically low-grade tumors on biopsy. Preoperative ureteroscopic biopsy is not recommended for UTUC patients who have been diagnosed based on CTU findings.

     

/

返回文章
返回